Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats

Journal of Biochemical and Molecular Toxicology

Volumn 28, Issue 10, 2014, Pages 472-479

  El Garhy, Amany M ^a   Abd El Raouf, Ola M ^a   El Sayeh, Bahia M ^b   Fawzy, Hala M ^a   Abdallah, Dalaal M ^b  

^a NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Cisplatin; Ellagic acid; Inflammation; Nephrotoxicity

Indexed keywords

CASPASE 3; CISPLATIN; CREATININE; ELLAGIC ACID; ENDOTHELIN 1; GAMMA GLUTAMYLTRANSFERASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; KIDNEY DYSFUNCTION; MALE; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; KIDNEY; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOOD UREA NITROGEN; CASPASE 3; CHEMOKINE CCL2; CISPLATIN; CREATININE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ELLAGIC ACID; ENDOTHELIN-1; GAMMA-GLUTAMYLTRANSFERASE; HEME OXYGENASE-1; KIDNEY; MALE; NF-KAPPA B; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84927574669     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21587     Document Type: Article

References (38)

1. Rehman MU, Tahir M, Ali F, Qamar W, Lateef A, Khan R, Sultana S. Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid. Mol Cell Biochem 2012;365(1-2):119-127.
2. Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 2002;50(7):2200-2206.
3. Pari L, Sivasankari R. Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats. Fundam Clin Pharmacol 2008;22(4):395-401.
4. Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G. Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol 2005;47(4):449-454.
5. Sepúlveda L, Ascacio A, Rodríguez-Herrera R, Aguilera-Carbó A, Aguilar CN. Ellagic acid: biological properties and biotecnological development for production processes. Afr J Biotechnol 2011;10(22):4518-4523.
6. Türk G, Çeribaşi AO, Sahna E, Ateşşahin A. Lycopene and ellagic acid prevent testicular apoptosis induced by cisplatin. Phytomedicine 2011;18(5):356-361.
7. Chatterjee A, Chatterjee S, Das S, Saha A, Chattopadhyay S, Bandyopadhyay SK. Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation. Acta Biochim Biophys Sin 2012;44(7):565-576.
8. Xiao HT, Tsang SW, Qin HY, Choi FF, Yang ZJ, Han Q B, Bian Z X. A bioactivity-guided study on the anti-diarrheal activity of Polygonum chinense Linn. J Ethnopharmacol 2013;149(2):499-505.
9. Chao CY, Mong MC, Chan KC, Yin MC. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 2010;54(3):388-395.
10. Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MR. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res 2007;24(5):899-908.
11. Ateşşahín A, Çeríbaşi AO, Yuce A, Bulmus Ö, Çikim G. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Nordic Pharmacol Soc Basic Clin Pharmacol Toxicol 2007;100:121-126.
12. Al-Kharusi N, Babiker HA, Al-Salam S, Waly MI, Nemmar A, Al-Lawati I, Yasin J, Beegam S, Ali BH. Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study. Eur Rev Med Pharmacol Sci 2013;17(3):299-310.
13. Institute of Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals, 8th edition. Washington, D.C.: National Academy Press; 1996.
14. Erdinç M, Erdinç L, Nergiz Y, Kelle I˙. The effects of nifedipine on renal perfusion pressure and kidney during cisplatin-induced nephrotoxicity in rats. Dicle Ti{dotless}p Dergisi 2007;34(4):248-253.
15. Miranda KM, Espey MG, Wink DA. A rapid simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5(1):62-71.
16. Marvaala EMA, Cheng ZJ, Tikkanen I, Lapatto R, Nurminen K, Vapaatalo H, Müller DN, Fiebeler A, Ganten U, Ganten D, Luft FC. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension 2001;37(2):414-422.
17. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334(2):115-124.
18. Ros E Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 2009;89(5):1649S-1656S.
19. Lee S, Ahn D. Expression of endothelin-1 and its receptors in cisplatin-induced acute renal failure in mice. Korean J Physiol Pharmacol 2008;12(4):149-153.
20. Chen HC, Guh JY, Shin SJ, Tsai JH, Lai YH. Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med 2000;135(4):309-315.
21. Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999;162(1):196-203.
22. Fiore G, Florio P, Micheli L, Nencini C, Rossi M, Cerretani D, Ambrosini G, Giorgi G, Petraglia F. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab 2005;90(7):4205-4210.
23. Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Sugaya T, Ruiz-Ortega M, Tomino A. Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. Antioxid Redox Signal 2005;7(9-10):1261-1268.
24. Nishihara K, Masuda S, Shinke H, Ozawa A, Ichimura T, Yonezawa A, Matsubara K. Urinary chemokine (CC motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity. Biochem Pharmacol 2013;85(4):570-582.
25. Viedt C, Dechend R, Fei J, Hänsch GM, Kreuzer J, Orth SR. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-κB and activating protein-1. J Am Soc Nephrol 2002;13(6):1534-1547.
26. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997;17(1):3-9.
27. Chen BY, Lin DP, Wu CY, Teng MC, Sun CY, Tsai YT, Su KC, Wang SR, Chang HH. Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation Mol. Vis 2011;17:854-863.
28. Nishimura M. Tumour necrosis factor alpha production by polymorphonuclear neutrophils treated with mouse anti-human CD19 monoclonal antibody. Cell Biochem Funct 2004;22(4):207-211.
29. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J InterferonCytokine Res 2009;29(6):313-326.
30. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110(6):835-842.
31. Chirino YI, Trujillo J, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, Bobadilla NA, Pedraza-Chaverri, J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 2008;176(1):48-57.
32. Rosillo MA, Sanchez-Hidalgo M, Cárdeno A, de la Lastra CA. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 2011;82(7):737-745.
33. Vanella L, Di Giacomo C, Acquaviva R, Barbagallo I, Li Volti G, Cardile V, Sorrenti V. Effects of ellagic acid on angiogenic factors in prostate cancer cells. Cancers 2013;5(2):726-738.
34. Alcaraz MJ, Fernandez P, Guillen M I. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 2003;9(30), 2541-2551.
35. Ryter S W, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling path-ways: Regulation and functional significance. Mol Cell Biochem 2002;234-235(1-2):249-263.
36. Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 2003;1:47-61.
37. Hseu YC, Chou CW, Senthil Kumar KJ, Fu KT, Wang HM, Hsu LS, Kuo YH, Wu CR, Chen SC, Yang HL. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem Toxicol 2012;50(5):1245-1255.
38. Türk G, Çeribaşi AO, Sakin F, Sönmez M, Ateşşahin A. Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis. Reprod Fertil Dev 2010;22(4):5870-596.